Evidence map›Paper›PMID 33441144›Full record

ArticleInternational journal for equity in health2021

Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China.

Xiaohan Wang, Leiyu Shi, Yuyao Zhang, Haiqian Chen, Gang Sun

Open access · goldAbstract read
In one paragraph

Article in International journal for equity in health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. The Advantages of the Zero-COVID-19 Strategy.International journal of environmental research and public health · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Xiaohan WangDepartment of Health Management, School of Health Management, Southern Medical University, Guangzhou, Guangdong, 510515, P.R. China.
Leiyu ShiDepartment of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
Yuyao ZhangDepartment of Health Management, School of Health Management, Southern Medical University, Guangzhou, Guangdong, 510515, P.R. China.
Haiqian ChenDepartment of Health Management, School of Health Management, Southern Medical University, Guangzhou, Guangdong, 510515, P.R. China.
Gang SunDepartment of Health Management, School of Health Management, Southern Medical University, Guangzhou, Guangdong, 510515, P.R. China. sunhoney163@163.com.ORCID 0000-0002-9642-2886
Southern Medical University · CNJohns Hopkins University · US

Funding

The National Social Science Fund of China ) No. 16BGL184
6 · The paper itself

Abstract

objectiveIn order to provide experiences for international epidemic control, this study systematically summarized the Coronavirus disease 2019 (COVID-19) prevention and control policies in Japan, Italy, China and Singapore, and also analyzed the possible inequalities that exist in these response approaches to improve global infectious disease control.

methodsWe summarized the epidemic prevention and control policies in Japan, Italy, China, and Singapore, and analyzed the policy effects of these four countries by using the data published by Johns Hopkins Coronavirus Resource Center.

resultsAs of May 27, 2020, the growing trend of new cases in Japan, Italy, China and Singapore has stabilized. However, the cumulative number of confirmed cases (231139) and case-fatality rate (14.3%) in Italy far exceeded those in the other three countries, and the effect of epidemic control was inferior. Singapore began to experience a domestic resurgence after April 5, with a cumulative number of confirmed cases reaching 32,876, but the case-fatality rate remained extremely low (0.1%). The growth of cumulative confirmed cases in China (84547) was almost stagnant, and the case-fatality rate was low (5.5%). The growth of cumulative confirmed cases in Japan (16661) increased slowly, and the case-fatality rate (4.8%) was slightly lower than that in China.

conclusionThis study divided the epidemic prevention and control policies of the four countries into two categories: the blocking measures adopted by China and Singapore, and the mitigation measures adopted by Japan and Italy. According to the Epidemic control results of these four countries, we can conclude that the blocking measures were generally effective. As the core strategy of blocking measures, admitting mild patients into hospital and cases tracing helped curb the spread of the outbreak in Singapore and China. Countries should choose appropriate response strategies on the premise of considering their own situation, increase investment in health resources to ensure global health equity, and eventually control the spread of infectious diseases in the world effectively.

Indexed as

Health PolicyChinaCommunicable Disease ControlCOVID-19Disease OutbreaksHealthcare DisparitiesHumansItalyJapanSARS-CoV-2SingaporeBlocking measuresCOVID-19Global health equityMitigation measuresPandemic response

Identifiers

PMID33441144
PMCPMC7804586
OpenAlexW3120422822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.